Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease

Third Department of Internal Medicine, Akita University School of Medicine, Akita Kumiai General Hospital, Akita, Japan.
Clinical nephrology (Impact Factor: 1.13). 02/2009; 71(1):9-20. DOI: 10.5414/CNP71009
Source: PubMed

ABSTRACT There are three subtypes of monoclonal immunoglobulin deposition disease: light chain deposition disease (LCDD), light and heavy chain deposition disease (LHCDD), and heavy chain deposition disease (HCDD). Although it has been considered that LHCDD is a variant of LCDD, information on clinicopathological features and prognosis in LHCDD is presently limited.
We reviewed 5,443 renal biopsies, and evaluated clinicopathological features and outcomes in patients with LHCDD, in comparison with those in patients with LCDD and previously reported patients with HCDD. We also characterized paraprotein deposits in patients with LHCDD.
We identified 6 patients with LHCDD, 6 patients with LCDD, and 1 patient with HCDD. The most common clinicopathological findings in patients with LHCDD were proteinuria, renal insufficiency, and nodular sclerosing glomerulopathy. Three patients had IgG-k deposits and 3 patients had IgG-l deposits. Heavy chain subclass analysis performed in 4 patients showed IgG3 deposits in all patients. Dual immunostaining revealed glomerular colocalization of light and heavy chains. In contrast with LCDD, glomerular C3 and C1q deposits were common findings in LHCDD and HCDD. All patients with LHCDD were treated with steroids and cytotoxic agents, but no effect on proteinuria was observed. Three patients developed end-stage renal disease requiring hemodialysis. The underlying hematological disorders in LHCDD and HCDD were milder than in LCDD. Early renal survival and overall patient survival in our patients appeared to be better in LHCDD than in LCDD.
There are apparent differences in clinicopathological features and prognosis between LHCDD and LCDD. LHCDD is probably more similar to HCDD.

1 Follower
16 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The biochemical characteristics of 1 37 strains of Citrobacter diversus (Burkey) Werkman and Gillen were determined, and the resulting data are summarized. Members of this species produced indole and ornithine decarboxylase and fermented adonitol but failed to grow in KCN medium. Detectable amounts of hydrogen sulfide were not produced in triple sugar-iron-agar medium but were formed by some strains in peptone-iron-agar. The nomenclature and taxonomic position of these bacteria are discussed, and information that should be helpful for their differentiation from Citrobacter freundii and Enterobacter cloacae is included. Strain 3613-63 (ATCC 27 156) is designated as the neotype strain and is described herein.
    International journal of systematic bacteriology 01/1972; 22(1). DOI:10.1099/00207713-22-1-12 · 2.27 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Kidney involvement is frequent in hematologic malignancies. It is associated with adverse outcome and treatment difficulties. It can affect every area of the renal parenchyma (tubules, interstitium, glomerulus, vessels). Various mechanisms could be implicated: deposits of immunoglobulin fractions or crystals, renal infiltration by malignant cells, urinary tract obstruction, paraneoplastic or storage glomerulopathies… Diagnostic strategy relies on the clinical presentation: acute renal failure, chronic kidney disease, glomerular proteinuria with or without nephrotic syndrome, tubular proteinuria, hydroelectrolytic disorders. In this review, we detail the diagnostic tests that are needed for the detection and the follow-up of renal involvement in hematologic malignancies, and clarify the indications of renal biopsy. We propose diagnostic strategies of renal involvement in myeloma, Waldenström's disease, high grade lymphomas and acute leukemias, low grade lymphomas and chronic leukemias. The adverse effects of treatments (chemotherapy, radiotherapy, stem cell graft …) are not addressed in this review.
    La Revue de Médecine Interne 10/2010; 31(10):685-696. DOI:10.1016/j.revmed.2009.08.013 · 1.07 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 68-year-old woman diagnosed with erosive rheumatoid arthritis (RA) was treated with intramuscular methotrexate 15 mg weekly and oral prednisone 5 mg daily. A favorable outcome of 6 years was followed by RA flare and nephrotic syndrome (NS). Renal biopsy revealed non-amyloid light-chain deposition disease. Laboratory analysis and bone marrow biopsy excluded monoclonal protein and plasma cell dyscrasia. Addition of subcutaneous etanercept, 25 mg twice weekly allowed rapid control of both arthritis and NS. To date, after over 7-year follow-up, RA is in clinical remission, 24-h albuminuria is consistently below 0.5 g, and serum creatinine is 0.9 mg/dl.
    International Urology and Nephrology 09/2011; 43(3):909-12. DOI:10.1007/s11255-010-9788-6 · 1.52 Impact Factor
Show more